SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-02-19 20:10
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,364,852
+718,800 vol
$3.29 each 		2,494,218
Filed 2025-02-19 20:09
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+177,000 vol 		1,658,003
Filed 2025-02-05 17:16
Tx date 2025-02-04 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-78,102.57
-23,790 vol
$3.28 each 		1,481,003
Filed 2024-02-05 21:46
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,188,240
+495,100 vol
$2.40 each 		1,775,418
Filed 2024-02-05 21:45
Tx date 2024-02-02 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,504.25
-10,164 vol
$2.31 each 		1,504,793
Filed 2024-02-05 21:44
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+123,800 vol 		1,514,957
Filed 2023-02-06 20:10
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$970,630
+334,700 vol
$2.90 each 		1,280,318
Filed 2023-02-06 20:08
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+83,700 vol 		1,391,157
Filed 2022-01-20 18:25
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$915,638
+325,850 vol
$2.81 each 		945,618
Filed 2021-02-18 09:20
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,078,170
+249,000 vol
$4.33 each 		619,768
Filed 2021-02-10 17:19
Tx date 2021-02-09 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-100,000
-20,000 vol
$5.00 each 		1,307,457
Filed 2020-12-16 17:14
Tx date 2020-12-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-200,000
-40,000 vol
$5.00 each 		1,327,457
Filed 2020-07-29 14:12
Tx date 2020-07-23 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-100,200
-20,000 vol
$5.01 each 		1,367,457
Filed 2020-02-19 14:52
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		370,768
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$477,565
+104,500 vol
$4.57 each 		170,768
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,387,457
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Holder: Michael J. McElhaugh Irrevocable Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		377,358
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		66,268